Kanaya Susan M

Avg. Two Year Performance

No purchase track record
(30%) Avg. Sale Return
(14%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(6%)(14%)(27%)(30%)(30%)
Sale Success Rate10 of 2011 of 2012 of 209 of 207 of 20
Drugs » Biotechnology

Sr. VP Finance and CFO:

Holdings: 98.85K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

See Remarks, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--